Belmont Pharmacy CE
HealthTrust Webinar June 12
- Event Begins Wednesday 12 June 2024
- Event Ends Saturday 29 June 2024
- Time 12:00 PM to 12:00 AM CDT
- 3 Confirmed People
Debate of the DOACs: A Comparison of Generic Dabigatran versus Rivaroxaban and Apixaban
June 12, 2024
1 contact hour
UAN: 0863-9999-24-067-L01-P
Presenter: Jana Kelly, PharmD, PGY1 Pharmacy Resident, McLeod Health, Florence, SC
1 contact hour
UAN: 0863-9999-24-067-L01-P
Presenter: Jana Kelly, PharmD, PGY1 Pharmacy Resident, McLeod Health, Florence, SC
Pharmacist Learning Objectives:
- Recall current evidence-based guidelines that assess the clinical indications and effectiveness for dabigatran, apixaban, and rivaroxaban
- Identify financial considerations in the use of dabigatran, apixaban, and rivaroxaban
- Recognize cases in which generic dabigatran may be an appropriate substitution for apixaban and rivaroxaban
Pharmacist Attendees: Click here to access evaluation